• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation.

作者信息

Zara J, Pomato N, McCabe R P, Bredehorst R, Vogel C W

机构信息

Department of Biochemistry, Georgetown University, Washington, D.C. 20007, USA.

出版信息

Bioconjug Chem. 1995 Jul-Aug;6(4):367-72. doi: 10.1021/bc00034a005.

DOI:10.1021/bc00034a005
PMID:7578355
Abstract

Human IgM monoclonal antibody 16-88, derived from patients immunized with autologous colon carcinoma cells, was derivatized with two different cross-linkers, S-(2-thiopyridyl)-L-cysteine hydrazide (TPCH), which is carbohydrate-directed, and N-succinimidyl-3-(2- pyridyldithio)propionate (SPDP), which is amino group-directed. Two antibody functions, antigen binding and complement activation, were assayed upon derivatization with TPCH and SPDP. TPCH allowed for extensive modification (up to 17 TPCH molecules per antibody) without impairment of antigen binding activity, while this function was significantly compromised upon derivatization with SPDP. Antibody molecules derivatized with 16 SPDP residues showed almost complete loss of their antigen binding function. The complement activating ability of antibody 16-88 was significantly decreased after derivatization with TPCH or SPDP. In the case of SPDP derivatization, this decrease of the complement activating ability is predominantly a consequence of the impaired binding function. Upon conjugation of cobra venom factor (CVF), a nontoxic 137-kDa glycoprotein which is capable of activating the alternative pathway of complement, the antigen binding activity of SPDP-derivatized antibody was further compromised, whereas that of TPCH-derivatized antibody remained unaffected even after attachment of three or four CVF molecules per antibody. In both conjugates CVF retained good functional activity. CVF was slightly more active when attached to SPDP-derivatized antibody, suggesting a better accessibility of amino group-coupled CVF for its interaction with other complement proteins. These results indicate that carbohydrate-directed conjugation compromises the antibody function of complement activation, but allows for the generation of immunoconjugates with unimpaired antigen binding capability.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation.
Bioconjug Chem. 1995 Jul-Aug;6(4):367-72. doi: 10.1021/bc00034a005.
2
A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates.一种用于合成免疫缀合物的碳水化合物导向的异双功能交联剂。
Anal Biochem. 1991 Apr;194(1):156-62. doi: 10.1016/0003-2697(91)90163-n.
3
Carbohydrate-directed conjugation of cobra venom factor to antibody by selective derivatization of the terminal galactose residues.
Bioconjug Chem. 2001 Mar-Apr;12(2):271-9. doi: 10.1021/bc000100u.
4
Antibody conjugates with cobra venom factor. Synthesis and biochemical characterization.
J Immunol Methods. 1987 Nov 23;104(1-2):159-72. doi: 10.1016/0022-1759(87)90500-x.
5
Preparation of immunoconjugates using antibody oligosaccharide moieties.使用抗体寡糖部分制备免疫缀合物。
Methods Mol Biol. 2004;283:87-108. doi: 10.1385/1-59259-813-7:087.
6
Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.不同单克隆抗体-眼镜蛇毒因子偶联物对人神经母细胞瘤细胞的相加细胞毒性。
Immunobiology. 1997 Nov;197(5):444-59. doi: 10.1016/s0171-2985(97)80078-2.
7
Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.胃肠道癌细胞上补体抗性因子CD46、CD55和CD59的频繁表达限制了单克隆抗体17-1A的治疗潜力。
J Surg Oncol. 1997 Mar;64(3):222-30. doi: 10.1002/(sici)1096-9098(199703)64:3<222::aid-jso9>3.0.co;2-c.
8
Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic.补体对人神经母细胞瘤细胞的杀伤作用:一种细胞毒性单克隆抗体及其F(ab')2-眼镜蛇毒因子缀合物具有同等的细胞毒性。
Mol Immunol. 1990 Oct;27(10):957-64. doi: 10.1016/0161-5890(90)90118-j.
9
The oligosaccharide chains of cobra venom factor are required for complement activation.眼镜蛇毒因子的寡糖链是补体激活所必需的。
Mol Immunol. 1989 Jun;26(6):563-74. doi: 10.1016/0161-5890(89)90008-4.
10
A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach.一种单克隆抗体-眼镜蛇毒因子偶联物通过两步法提高了99mTc标记的抗癌胚抗原抗体的肿瘤特异性摄取。
Cancer Res. 1995 Dec 1;55(23 Suppl):5749s-5755s.

引用本文的文献

1
Biotargeted nanomedicines for cancer: six tenets before you begin.生物靶向纳米药物治疗癌症:开始之前的六大准则。
Nanomedicine (Lond). 2013 Feb;8(2):299-308. doi: 10.2217/nnm.13.3.